![Randal A. Hassler](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Randal A. Hassler
Keine laufenden Positionen mehr
Karriereverlauf von Randal A. Hassler
Ehemalige bekannte Positionen von Randal A. Hassler
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Seattle Biomedical Research Institute
![]() Seattle Biomedical Research Institute Miscellaneous Commercial ServicesCommercial Services Seattle Biomedical Research Institute operates as a non-profit organization that researches and discovers infectious diseases. It provides research for new drugs, vaccines, and diagnostics. The company was founded by Kenneth D. Stuart and Ruth W. Shearer in 1976 and is headquartered in Seattle, WA. | Geschäftsführer | 01.01.2008 | 01.01.2014 |
Finanzdirektor/CFO | 22.11.2010 | 01.01.2014 | |
AMGEN INC. | Corporate Officer/Principal | 01.01.1995 | 01.01.2007 |
ALDER BIOPHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.08.2014 | - |
Ausbildung von Randal A. Hassler
Indiana University | Undergraduate Degree |
Colorado State University | Graduate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Operativ
Corporate Officer/Principal | 2 |
Chief Operating Officer | 1 |
Director of Finance/CFO | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
AMGEN INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Seattle Biomedical Research Institute
![]() Seattle Biomedical Research Institute Miscellaneous Commercial ServicesCommercial Services Seattle Biomedical Research Institute operates as a non-profit organization that researches and discovers infectious diseases. It provides research for new drugs, vaccines, and diagnostics. The company was founded by Kenneth D. Stuart and Ruth W. Shearer in 1976 and is headquartered in Seattle, WA. | Commercial Services |
Lundbeck Seattle BioPharmaceuticals, Inc.
![]() Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA. | Health Technology |
- Börse
- Insiders
- Randal A. Hassler
- Erfahrung